{"id":7138,"date":"2026-11-02T12:00:00","date_gmt":"2026-11-02T12:00:00","guid":{"rendered":"https:\/\/vbc-vaccines.com\/?p=7138"},"modified":"2026-11-03T09:41:20","modified_gmt":"2026-11-03T09:41:20","slug":"vbc-pcv13-walvax-technology-transfer","status":"publish","type":"post","link":"https:\/\/vbc-vaccines.com\/ar\/vbc-pcv13-walvax-technology-transfer\/","title":{"rendered":"VBC Launches Implementation Phase for Egypt\u2019s First Locally Manufactured PCV13 Vaccine"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Under the patronage and in the presence of <strong>H.E. Prof. Dr. Khaled Abdel Ghaffar<\/strong>, Minister of Health and Population, <strong>\u0645\u062f\u064a\u0646\u0629 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0648\u0627\u0644\u0628\u064a\u0648\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u0649<\/strong> launched the implementation phase for localizing the first locally manufactured PCV13 vaccine in Egypt, signing the technology transfer agreement with <strong>Yuxi Walvax Biotechnology<\/strong>, its strategic technology partner with World Health Organization prequalified facilities.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Prof. Dr. Magdy El Sayed<\/strong>, CEO of VBC, opened the event by presenting the strategic vision for Egypt\u2019s first locally made PCV13, along with the site\u2019s readiness and bioprocessing capabilities, describing the milestone as a turning point for vaccine localization and national health security. The event brought together <strong>Dr. Hisham Stait<\/strong>, Chairman of the Egyptian Unified Procurement Authority (UPA); <strong>Dr. Tamer Elhoseiny<\/strong>, Vice Chairman of the Egyptian Drug Authority (EDA); <strong>Dr. Dong Shaozhong<\/strong>, Vice Chairman of Walvax Group and Chairman of Yuxi Walvax; <strong>Mr. Kamal Ebeed<\/strong> of the African Pooled Procurement Mechanism (APPM), Africa CDC; <strong>Mr. Yang Huazhi (Aaron)<\/strong>, Director of the Global Sales Department at Walvax Group; <strong>Prof. Xuan-Yi Wang<\/strong> of Fudan University; and <strong>Prof. Dr. Mohamed Ghandour<\/strong>, Consultant in Pediatrics and Neonatology. The agreement was signed in the presence of H.E. the Minister, followed by a tour of VBC\u2019s manufacturing facilities.<\/p>\n<p class=\"wp-block-paragraph\">This partnership advances Egypt Vision 2030 and the African Union\u2019s Agenda 2063, supporting vaccine self-sufficiency and strengthening supply security at the national and African levels.<\/p>\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\"><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"586\" data-id=\"7135\" src=\"https:\/\/vbc-vaccines.com\/wp-content\/uploads\/2026\/11\/vbc-pcv13-walvax-tech-transfer-2.jpg\" class=\"wp-image-7135\"\/><\/figure><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"800\" height=\"585\" data-id=\"7136\" src=\"https:\/\/vbc-vaccines.com\/wp-content\/uploads\/2026\/11\/vbc-pcv13-walvax-tech-transfer-3.jpg\" class=\"wp-image-7136\"\/><\/figure><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"800\" height=\"600\" data-id=\"7137\" src=\"https:\/\/vbc-vaccines.com\/wp-content\/uploads\/2026\/11\/vbc-pcv13-walvax-tech-transfer-4.jpg\" class=\"wp-image-7137\"\/><\/figure><\/figure>","protected":false},"excerpt":{"rendered":"<p>Under the patronage and in the presence of H.E. Prof. Dr. Khaled Abdel Ghaffar, Minister of Health and Population, Vaccines and Biotechnology City (VBC) launched the implementation phase for localizing the first locally manufactured PCV13 vaccine in Egypt, signing the technology transfer agreement with Yuxi Walvax Biotechnology, its strategic technology partner with World Health Organization prequalified facilities. Prof. Dr. Magdy &hellip;<\/p>","protected":false},"author":4,"featured_media":7134,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-7138","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry"],"_links":{"self":[{"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/posts\/7138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/comments?post=7138"}],"version-history":[{"count":1,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/posts\/7138\/revisions"}],"predecessor-version":[{"id":7139,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/posts\/7138\/revisions\/7139"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/media\/7134"}],"wp:attachment":[{"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/media?parent=7138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/categories?post=7138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vbc-vaccines.com\/ar\/wp-json\/wp\/v2\/tags?post=7138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}